Demir, F. Et Al. 2021. Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies. Hypertension , vol.77, no.5 , 1559-1570.

Demir, F., Urayama, K., Audebrand, A., Toprak-Semiz, A., Steenman, M., Kurose, H., ... Nebigil, C. G.(2021). Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies. Hypertension , vol.77, no.5, 1559-1570.

Demir, Ferda Et Al. "Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies," Hypertension , vol.77, no.5, 1559-1570, 2021

Demir, Ferda Et Al. "Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies." Hypertension , vol.77, no.5, pp.1559-1570, 2021

Demir, F. Et Al. (2021) . "Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies." Hypertension , vol.77, no.5, pp.1559-1570.

@article{article, author={Ferda Demir Et Al. }, title={Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies}, journal={Hypertension}, year=2021, pages={1559-1570} }